Acceleron and Celgene Announce Updated Results from Phase 2 Studies of Luspatercept in Beta-Thalassemia Presented at the 58th Annual Meeting of the American Society of Hematology
Acceleron and Celgene Announce Updated Results from Ongoing Phase 2 Studies of Luspatercept in Myelodysplastic Syndromes at the 58th Annual Meeting of the American Society of Hematology
Genentech’s Gazyva Helped People With Previously Untreated Follicular Lymphoma Live Significantly Longer Without Their Disease Worsening Compared to Rituxan
Move comes at a time when industry is struggling from new regulations.
The primary reason for the Department of Labor's fiduciary rule doesn't involve protecting qualified retirement plans but rather unsuspecting IRA owners.
Who can do these beneficial transfers, with how much money, to what kinds of charities--and how to execute (and report) the QCD.
Unlike other tax-deferred account types, IRAs have a unique 'minimum distribution rule' for surviving spouses.
It may sound strange, but this technique can work well in some circumstances.
Prudent Investor Advisors' W. Scott Simon analyzes a series of agreements between a large insurance company and a K-12 school district.
Mind the deadline for taking a 'corrective distribution.'